CVS pharmacy is expanding its pharmacy-branded coverage to include vaccines, as part of a partnership with the Food and Drug Administration.
According to a press release, the expanded coverage comes on the heels of the agency announcing it would soon begin allowing CVS Pharmacy to offer vaccines through its network.
“We are excited to be able to extend our coverage to new vaccines for those who need it most,” said Dr. Steven W. Smith, Vice President of Global Medical Affairs for CVS Pharmaceuticals.
“As more and more people receive vaccines, CVS has a unique opportunity to help them manage the vaccine-associated medical issues that we all face, including vaccination.”
CVS Pharmacies has previously offered vaccine coverage for a range of vaccines including pneumococcal conjugate vaccine (PCV-6), influenza vaccine (AFLV-19), and MMR vaccines (MMR-16, MMR-17, and MMR-18).
This expansion to vaccine coverage comes a month after the FDA announced it would begin allowing pharmaceuticals to offer vaccine coverage on their own channels, which was a first for the pharmacy chain.
The FDA’s move follows CVS pharmacies’ acquisition of a large portion of the flu vaccine distribution network that previously was run by the American Hospital Association (AHA).
The new vaccine coverage will not only cover vaccines in CVS’ pharmacy network, but will also apply to vaccine delivery through CVS Health’s network.
The new expanded coverage, which is expected to launch next month, will allow CVS to help customers manage vaccine issues as well as vaccine reactions that may occur as a result of the vaccines being administered.
CHSANews.com (CVS) is an unbiased, one-stop resource for healthcare professionals and healthcare consumers, providing information, resources, and news that matters to the health care system.
For more information on health care issues, visit www.cvs.com or follow @CVSHealth on Twitter.
Read more about CVS at: